Tokyo, July 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058513) titled 'Investigation of adapting transcutanoues electrical nerve stimulation using quantitative sensory testing on movement-evoked pain' on July 18.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Placebo
Primary Sponsor:
Institute - Kio university
Condition:
Condition - patients with movement-evoked pain
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the adapting transcutaneous electrical nerve stimulation on movement-evoked pain at pain phenotypes using quantitative sensory testing
To assess the impact of transcutaneous electrical nerve stimulation using quantitative sensory testing
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Low frequency-transcutaneous electrical nerve stimulation
Interventions/Control_2 - High frequency-transcutaneous electrical nerve stimulation
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - a
Key exclusion criteria - a
Target Size - 20
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2023 Year 01 Month 31 Day
Anticipated trial start date - 2023 Year 02 Month 20 Day
Last follow-up date - 2025 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059681
Disclaimer: Curated by HT Syndication.
